Rehabilitation and Medical Centers
East Tallinn Central Hospital
Service Guide Prevention and Treatment of addiction (drugs and alcohol)
East Tallinn Central Hospital
Tallinn: Ravi 18, Pärnu mnt 104, Energia 8, Hariduse 6, Magasini 34
Phone: 372 622 7070
Fax: 372 620 7002
There are 7 individual clinics at the heart of East-Tallinn Central Hospital – Diagnostic Clinic, Clinic of Internal Medicine, Eye Clinic, Women`s Clinic, Surgery Clinic, Clinic of Medical Rehabilitation and Long-Term Nursing Clinic. Clinics in turn include centers and departments which are focused on a specialty in a more strict meaning. Medical operation is supported by administration and several services.
Facts and stats
The most recent data on drug use in the general population are based on a survey conducted in 2008 among people aged 15–69. Whilst a 2003 survey found that 15 % of people aged 15–64 had tried drugs at some point in their lives, the 2008 survey found that 21 % of people in the same age group had tried drugs.
Lifetime prevalence of drug use had increased in both the older and the younger age groups, but it was considerably higher in the younger age groups. The increase was particularly significant in the 25–34 age group, where 36 % of people had already tried an illicit drug at least once in their lifetime (16 % in 2003).
The European School Survey Project on Alcohol and Other Drugs (ESPAD) has been conducted regularly in Estonia since 1995. The latest survey was in 2011, based on a nationwide sample of schoolchildren aged 15−16. The results for the 15- to 16-year-old age group for 1995–2007 revealed an increase in prevalence rates for illicit drug use, with some stabilisation signs in the latest available study.
Lifetime experience of any illicit drug other than marijuana and hashish more than tripled between 1995 (2 %) and 1999 (9 %), and reached 10 % in 2003, but declined to 8 % in 2011. In 1995 some 7 % reported lifetime use of marijuana/hashish, 23 % in 2003, 26 % in 2007 and 24 % in 2011.
Lifetime use of ecstasy, which increased from 3 % in 1999 to 6 % in 2007, had dropped to 3 % in 2009. In 2003, the lifetime prevalence of amphetamine use was 7 % and in 2011 it had decreased to 3 %.
The most recent survey indicates a last year prevalence of cannabis use of 17 %, and last month prevalence of 6 %. In terms of gender distribution, boys reported use of illicit substances more frequently than girls; however, prevalence rates among boys remained stable in 2011 compared to the results of 2007 study, while among girls there was an increase in prevalence in the same time period.
Governmental / Non-governmental Associations
The National Institute for Health Development
The National Institute for Health Development,
Hiiu 42, 11619 Tallinn
Fax: +372 659 3901
Tel: +372 659 3900
The National Institute for Health Development is a government established research and development body collecting, connecting and providing reliable national information from a multitude of sources, related to the health of the Estonian population.
Our mission is to establish and share health related knowledge as well as to influence health behavior and determinants of health so as to increase the wellbeing of the people in Estonia and help them live longer and healthier lives.
We engage in public health related research and health promotion as well as development and implementation of disease prevention programmes and activities. Our further responsibilities include the administration of Estonian national health statistics and five population based registers and databases.